Properties and usefulness of the original K-562 human myelogenous leukemia cell line
about
Myeloperoxidase is involved in H2O2-induced apoptosis of HL-60 human leukemia cellsEffect of the R569W missense mutation on the biosynthesis of myeloperoxidaseThe landscape of histone modifications across 1% of the human genome in five human cell linesInfluence of RARalpha gene on MDR1 expression and P-glycoprotein function in human leukemic cellsA Novel Role for Progesterone Receptor Membrane Component 1 (PGRMC1): A Partner and Regulator of FerrochelataseAnalysis of the CD1 antigen presenting system in humanized SCID miceHuman p53 oncogene contains one promoter upstream of exon 1 and a second, stronger promoter within intron 1.Complex exon-intron marking by histone modifications is not determined solely by nucleosome distribution.A human monocytic NF-κB fluorescent reporter cell line for detection of microbial contaminants in biological samplesNatural killer cell mediated cytotoxic responses in the Tasmanian devilAcute myeloblastic leukemia in paroxysmal nocturnal hemoglobinuria. Evidence of evolution from the abnormal paroxysmal nocturnal hemoglobinuria clone.Induction of terminal differentiation in human K562 erythroleukemia cells by arabinofuranosylcytosine.Use of transcriptional signatures induced in lymphoid and myeloid cell lines as an inflammatory biomarker in Type 1 diabetesZNF300 knockdown inhibits forced megakaryocytic differentiation by phorbol and erythrocytic differentiation by arabinofuranosyl cytidine in K562 cellsCharacterization of miRNomes in acute and chronic myeloid leukemia cell lines.Transgene expression study of CXCR4 active mutants. Potential prospects in up-modulation of homing and engraftment efficiency of hematopoietic stem/progenitor cells.A set of imprinted genes required for normal body growth also promotes growth of rhabdomyosarcoma cells.Aggregatibacter actinomycetemcomitans leukotoxin induces cytosol acidification in LFA-1 expressing immune cells.Timing within the menstrual cycle, sex, and the use of oral contraceptives determine adrenergic suppression of NK cell activity.Effect of a factor released by K562 malignant cells in culture on human neutrophil bactericidal activityPorcine CD3(+)NKp46(+) Lymphocytes Have NK-Cell Characteristics and Are Present in Increased Frequencies in the Lungs of Influenza-Infected AnimalsPromiscuous targeting of bromodomains by bromosporine identifies BET proteins as master regulators of primary transcription response in leukemia.Predicting cancer-relevant proteins using an improved molecular similarity ensemble approach.A novel form of hereditary myeloperoxidase deficiency linked to endoplasmic reticulum/proteasome degradation.Regulated expression of CXCR4 constitutive active mutants revealed the up-modulated chemotaxis and up-regulation of genes crucial for CXCR4 mediated homing and engraftment of hematopoietic stem/progenitor cells.NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphoma.Identification of Id2 as a globin regulatory protein by representational difference analysis of K562 cells induced to express gamma-globin with a fungal compound.Secretion of IL-1β from imatinib-resistant chronic myeloid leukemia cells contributes to BCR-ABL mutation-independent imatinib resistance.Polymorphonuclear neutrophils and granulocytic myeloid-derived suppressor cells inhibit natural killer cell activity toward Aspergillus fumigatus.Cre/loxP-mediated excision of a neomycin resistance expression unit from an integrated retroviral vector increases long terminal repeat-driven transcription in human hematopoietic cells.The Fc Domain of Immunoglobulin Is Sufficient to Bridge NK Cells with Virally Infected Cells.CD56 Is a Pathogen Recognition Receptor on Human Natural Killer Cells.Distinct biological impact of dephosphorylation vs. downregulation of p210Bcr-Abl: implications for imatinib mesylate response and resistance.NKp46 defines a subset of bovine leukocytes with natural killer cell characteristics.Fibronectin receptor overexpression and loss of transformed phenotype in a stable variant of the K562 cell line.History and classification of human leukemia-lymphoma cell lines.Detecting T-cell reactivity to whole cell vaccines: Proof of concept analysis of T-cell response to K562 cell antigens in CML patients.In vitro combined effects of a triazene compound and interferon-beta on natural immunity against lymphoblastoid cells: studies at effector and target cell level.Drug-mediated changes in the susceptibility of human lymphoblastoid B cells to NK-mediated cytolysis: studies with a triazene compound.Ectosialyltransferase activity: a marker for certain human haematopoietic cells.
P2860
Q22254048-C3DAA446-223E-43B1-8E09-4E67B7AEB8E9Q24336913-CC2DDED3-D142-4F92-B6B8-A8F429375774Q24673723-DEB3904A-1A27-4BE2-ADE1-7514D97AEA72Q24814794-AE544FC0-3483-4C61-9F66-B5ABE2692B26Q28118692-5D321633-F92F-4F19-AFD2-44D475209C29Q28743012-344B2904-A0F7-4C2D-B945-312EA45B8B06Q33632309-E953C7FF-6093-4248-9214-C2FEB3368CE8Q33680184-14B3A4DF-66A5-4F51-BA39-A50236F0776DQ33724996-9A555C7F-0640-402C-87D3-97DCA63CD6A6Q34034657-C00128B2-C2DD-4427-AEA6-7E83D74BEB4CQ34556908-4F731928-AC28-4B32-9B2B-850D28A98829Q34613591-CA73FED5-94DA-4DD6-9EB2-7FBD903D1465Q35062538-C55D5164-865B-418E-A7B0-5FD113F25805Q35499791-E081C657-D2EA-42D3-BC7E-E48F88165B30Q35543478-5E9101E5-B1B3-4FA4-BF4C-4F41943A35D1Q36124735-FB0477E2-CEFF-44B6-B2DD-78B179F4CB36Q36169619-304A966E-F159-4FEE-AA0E-7FEC90445C01Q36460084-A5B8B802-7924-43A0-963C-D1246D7E2229Q36621650-F95F619B-16D1-473A-8EAC-607F38B631FFQ36967011-54F79D00-BF9A-44BF-B207-F37A13D090C8Q37092570-9ECF741D-6824-42B6-B7BC-B48A2690A0FFQ37334404-BB06D5EE-D366-4286-B33C-65DD4B809629Q37362677-5AEF1F6D-4C5A-4F45-ACB6-65F708E5BA9EQ37383836-8492EB92-8ABE-4836-BA95-A12422A12BEDQ37536210-16780590-3245-411C-9E68-C7CFB92EBF9DQ37708827-36C13812-4791-4E20-B09F-9BFEA0723357Q38324674-8DCDA299-9653-4125-BF14-48E7C568C6DBQ38797633-E85C46DC-AFEC-482D-85A4-B864B519A9CFQ38869334-31557B2A-3702-4F66-B154-D94880E63090Q39881411-51655DA5-52E1-4A43-8F77-CFA5945E0CA2Q40116692-32B5B705-2783-4FDD-AFEC-34EEA4985670Q40124282-2A0C0719-497E-4C91-B9FD-59B83779FA20Q40233193-6AEC292A-1AF2-4899-8597-A2BAAE933F4BQ40584277-FDACD821-62A8-4514-87EB-25B72172E913Q40641710-B9C8127E-11A9-45B0-ADFF-EFE72074A862Q40985478-429F3A23-D744-48F5-821A-FC02C3EB9089Q41275812-777DB623-D417-485E-A493-7B28861DADB5Q41432551-1E15AB30-7B09-4507-8282-46F3A8E08071Q41440667-2A799A7D-9D0A-4888-AA2E-E974057A2A90Q41505251-87068C7D-33C5-42D0-A65F-C575CDD7BB10
P2860
Properties and usefulness of the original K-562 human myelogenous leukemia cell line
description
1979 nî lūn-bûn
@nan
1979 թուականին հրատարակուած գիտական յօդուած
@hyw
1979 թվականին հրատարակված գիտական հոդված
@hy
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
name
Properties and usefulness of the original K-562 human myelogenous leukemia cell line
@ast
Properties and usefulness of the original K-562 human myelogenous leukemia cell line
@en
Properties and usefulness of the original K-562 human myelogenous leukemia cell line
@nl
type
label
Properties and usefulness of the original K-562 human myelogenous leukemia cell line
@ast
Properties and usefulness of the original K-562 human myelogenous leukemia cell line
@en
Properties and usefulness of the original K-562 human myelogenous leukemia cell line
@nl
prefLabel
Properties and usefulness of the original K-562 human myelogenous leukemia cell line
@ast
Properties and usefulness of the original K-562 human myelogenous leukemia cell line
@en
Properties and usefulness of the original K-562 human myelogenous leukemia cell line
@nl
P3181
P1433
P1476
Properties and usefulness of the original K-562 human myelogenous leukemia cell line
@en
P2093
B B Lozzio
C B Lozzio
P304
P3181
P356
10.1016/0145-2126(79)90033-X
P407
P577
1979-01-01T00:00:00Z